• Home
  • NEW DAY MEDICINE
  • 6 (80) 2025
  • 125 -6 (80) 2025- Agababyan I.R., Rustamova S.B. - THE ROLE OF EPICARDIAL ADIPOSE TISSUE IN THE DEVELOPMENT OF CARDIOVASCULAR DISEASES

125 -6 (80) 2025- Agababyan I.R., Rustamova S.B. - THE ROLE OF EPICARDIAL ADIPOSE TISSUE IN THE DEVELOPMENT OF CARDIOVASCULAR DISEASES

THE ROLE OF EPICARDIAL ADIPOSE TISSUE IN THE DEVELOPMENT OF CARDIOVASCULAR DISEASES

Agababyan I.R. - Samarkand State Medical University

Rustamova S.B. - Republican Specialized Scientific and Practical Medical Center of Cardiology Uzbekistan

Resume

Epicardial adipose tissue (EAT) is the true visceral adipose tissue of the heart, which normally makes up 20% of cardiac mass.The fact that adipose tissue performs not only a heat-insulating function, but also a function of energy storage (in the form of triglycerides) has been known for more than 30 years.Heart failure with preserved ejection fraction (HFpEF) is a complex condition characterized by high morbidity and mortality, often in the context of multiple comorbidities such as obesity. The pathophysiology of HFpEF includes emerging evidence that epicardial adipose tissue (EAT) or epicardial fat has an important function

Keywords: epicardial adipose tissue, heart failure, obesity,magnetic resonance imaging

First page

637

Last page

641

For citation:Agababyan I.R., Rustamova S.B. - THE ROLE OF EPICARDIAL ADIPOSE TISSUE IN THE DEVELOPMENT OF CARDIOVASCULAR DISEASES//New Day in Medicine 6(80)2025 637-641 https://newdayworldmedicine.com/en/new_day_medicine/6-80-2025

List of References

  1. Antonopoulos A. S. et al. Epicardial adipose tissue in myocardial disease: from physiology to heart failure phenotypes //Current Problems in Cardiology. – 2023. – Т. 48. – №. 10. – С. 101841.
  2. Arshi B. et al. Epicardial fat volume, cardiac function, and incident heart failure: the Rotterdam study //Journal of the American Heart Association. – 2023. – Т. 12. – №. 1. – С. e026197.
  3. Choy M. et al. Association between epicardial adipose tissue and incident heart failure mediating by alteration of natriuretic peptide and myocardial strain //BMC medicine. – 2023. – Т. 21. – №. 1. – С. 117.
  4. Doesch C. et al. Epicardial adipose tissue in patients with heart failure //Journal of Cardiovascular Magnetic Resonance. – 2010. – Т. 12. – С. 1-9.
  5. Iacobellis G. Epicardial adipose tissue in contemporary cardiology //Nature reviews cardiology. – 2022. – Т. 19. – №. 9. – С. 593-606.
  6. Jin X. et al. Epicardial adipose tissue related to left atrial and ventricular function in heart failure with preserved versus reduced and mildly reduced ejection fraction //European journal of heart failure. – 2022. – Т. 24. – №. 8. – С. 1346-1356.
  7. Kenchaiah S. et al. Pericardial fat and the risk of heart failure //Journal of the American College of Cardiology. – 2021. – Т. 77. – №. 21. – С. 2638-2652.
  8. Mazurek T. et al. Human epicardial adipose tissue is a source of inflammatory mediators //Circulation. – 2003. – Т. 108. – №. 20. – С. 2460-2466.
  9. Packer M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium //Journal of the American College of Cardiology. – 2018. – Т. 71. – №. 20. – С. 2360-2372.
  10. Pugliese N. R. et al. Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure //European Journal of Heart Failure. – 2021. – Т. 23. – №. 11. – С. 1858-1871.
  11. Rossi VA, Gruebler M, Monzo L, Galluzzo A, Beltrami M. The Different Pathways of Epicardial Adipose Tissue across the Heart Failure Phenotypes: From Pathophysiology to Therapeutic Target. Int J Mol Sci. 2023 Apr 6;24(7):6838. doi: 10.3390/ijms24076838. PMID: 37047810; PMCID: PMC10095298
  12. Sacks H. S. et al. Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat //The Journal of Clinical Endocrinology & Metabolism. – 2009. – Т. 94. – №. 9. – С. 3611-3615.
  13. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007 Jun;153(6):907-17. doi: 10.1016/j.ahj.2007.03.019. PMID: 17540190.)
  14. Talman A. H. et al. Epicardial adipose tissue: far more than a fat depot //Cardiovascular diagnosis and therapy. – 2014. – Т. 4. – №. 6. – С. 416.
  15. van Woerden G. et al. Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction //European journal of heart failure. – 2018. – Т. 20. – №. 11. – С. 1559-1566.
  16. van Woerden G. et al. Epicardial adipose tissue and outcome in heart failure with mid-range and preserved ejection fraction //Circulation: Heart Failure. – 2022. – Т. 15. – №. 3. – С. e009238.
  17. van Woerden G. et al. Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives //European Journal of Heart Failure. – 2022. – Т. 24. – №. 12. – С. 2238-2250.
  18. Ying W, Sharma K, Yanek LR, Vaidya D, Schär M, Markl M, Subramanya V, Solei- mani S, Ouyang P, Michos ED, et al. Visceral adiposity, muscle composition, and exercise tolerance in heart failure with preserved ejection fraction. ESC Heart Fail. 2021;8(4):2535–45.
  19. Агабабян И. Р., Искандарова Ф. И., Мухтаров С. Н. Роль маркеров воспаления жировой ткани как основной фактор в развитии артериальной гипертензии у больных метаболическим синдромом //The priorities of the world science: experiments and scientific debate. – 2019. – С. 25-30.
  20. Агабабян, И. Р., & Джаббарова, Н. М. (2023). Статины в лечении неалкогольной жировой болезни печени // Zamonaviy fan va ta'lim yangiliklari xalqaro ilmiy jurnal, 1(4), 104-116.

    file

    download